Imaging Retinal Vasculature in Infant Eyes - Trial NCT05558059
Access comprehensive clinical trial information for NCT05558059 through Pure Global AI's free database. This phase not specified trial is sponsored by Duke University and is currently Not yet recruiting. The study focuses on Retinopathy of Prematurity. Target enrollment is 16 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Handheld Optical Coherence Tomography with OCT Angiography
Observational
device
Sponsor & Location
Duke University
Timeline & Enrollment
N/A
Dec 31, 2022
Aug 31, 2027
Primary Outcome
Change in vascular density of intermediate and deep vascular plexus at the fovea and perifovea
Summary
Retinopathy of prematurity is a leading cause of childhood blindness worldwide. The fovea, a
 critical location in the retina determining visual acuity and visual function, and the blood
 vessels around it, are abnormally developed in infants with retinopathy of prematurity.
 However, how these blood vessels form during development of the human fovea remains unclear.
 This research will advance our understanding of the fundamental knowledge of how the blood
 vessels around the fovea form in infants, and how they change in diseased states such as
 preterm birth or retinopathy of prematurity.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05558059
Device Trial